PNPLA1
Omega-hydroxyceramide transacylase
Also known as: dJ50J22.1, FLJ38755, PLPL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N8W4
- Gene
- PNPLA1
- Ensembl
- ENSG00000180316
- Chromosome
- 6
- Canonical length
- 532 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to the patatin-like phospholipase (PNPLA) family, which is characterized by the presence of a highly conserved patatin domain. PNPLA family members have diverse lipolytic and acyltransferase activities, and are key elements in lipid metabolism. While other members of this family have been well characterized, the function of this gene remained an enigma. However, recent studies show that this gene is expressed in the skin epidermal keratinocytes, and has a role in glycerophospholipid metabolism in the cutaneous barrier. Consistent with these observations, mutations in this gene are associated with ichthyosis in human (autosomal recessive congenital ichthyoses, ARCI) and dog. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
532 residues, UniProt reviewed canonical sequence.
>Q8N8W4|PNPLA1
1 MEEQVFKGDP DTPHSISFSG SGFLSFYQAG AVDALRDLAP RMLETAHRFA GTSAGAVIAA
61 LAICGIEMDE YLRVLNVGVA EVKKSFLGPL SPSCKMVQMM RQFLYRVLPE DSYKVTTGKL
121 HVSLTRLTDG ENVVVSEFTS KEELIEALYC SCFVPVYCGL IPPTYRGVRY IDGGFTGMQP
181 CAFWTDAITI STFSGQQDIC PRDCPAIFHD FRMFNCSFQF SLENIARMTH ALFPPDLVIL
241 HDYYYRGYED AVLYLRRLNA VYLNSSSKRV IFPRVEVYCQ IELALGNECP ERSQPSLRAR
301 QASLEGATQP HKEWVPKGDG RGSHGPPVSQ PVQTLEFTCE SPVSAPVSPL EQPPAQPLAS
361 STPLSLSGMP PVSFPAVHKP PSSTPGSSLP TPPPGLSPLS PQQQVQPSGS PARSLHSQAP
421 TSPRPSLGPS TVGAPQTLPR SSLSAFPAQP PVEELGQEQP QAVALLVSSK PKSAVPLVHV
481 KETVSKPYVT ESPAEDSNWV NKVFKKNKQK TSGTRKGFPR HSGSKKPSSK VQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNPLA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- skin: 23 nTPM
- kidney: 4.4 nTPM
- bone marrow: 4.1 nTPM
- stomach: 1.8 nTPM
- small intestine: 0.9 nTPM
- testis: 0.9 nTPM
Single-cell type
- neutrophils: 89 nCPM
- parietal cells: 39 nCPM
- proximal tubule cells: 35 nCPM
- neutrophil progenitors: 12 nCPM
- sertoli cells: 9.2 nCPM
- monocytes: 6.1 nCPM
Immune cell
- basophil: 70 nTPM
- eosinophil: 19 nTPM
- neutrophil: 6.2 nTPM
- classical monocyte: 4 nTPM
- intermediate monocyte: 2.2 nTPM
- myeloid DC: 1.8 nTPM
Brain region
- cerebral cortex: 1.7 nTPM
- cerebellum: 1.6 nTPM
- white matter: 1.5 nTPM
- pons: 1.3 nTPM
- thalamus: 1.3 nTPM
- hypothalamus: 1.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNPLA1.
Disease | AllUniProt
Conditions PNPLA1 is implicated in, by any mechanism.
- Ichthyosis, congenital, autosomal recessive 10 (ARCI10) MIM:615024
Disease | GeneticClinVar
50 pathogenic / likely-pathogenic of 276 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive congenital ichthyosis 10
- Congenital ichthyosiform erythroderma
- Lamellar ichthyosis
- Ichthyosis
- Autosomal recessive congenital ichthyosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- lipid homeostasis
- triglyceride catabolic process
- omega-hydroxyceramide biosynthetic process
Molecular functions
- acyltransferase activity, transferring groups other than amino-acyl groups
- structural constituent of skin epidermis
- triacylglycerol lipase activity
- omega-hydroxyceramide transacylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Patatin-like phospholipase domain
- Acyl transferase/acyl hydrolase/lysophospholipase
- Patatin-like phospholipase domain-containing protein
- Patatin-like phospholipase
- Omega-hydroxyceramide transacylase PNPLA1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNPLA1 as an antibody target. Whether an autoantibody or antibody against PNPLA1 could matter depends on whether native PNPLA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNPLA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNPLA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...